I. Once-weekly Long-acting Insulin Analog: Characteristics and Clinical Application of Insulin Icodec

Key Points

• This research investigates the characteristics and clinical application of the weekly long-acting insulin analog, insulin icodec.
• Introduced insulin icodec as a new long-acting insulin formulation
• Evaluated the reduction in injection frequency
• Assessed risks associated with hypoglycemia
• Analyzed the benefit-risk profile
• Insulin icodec reduces the number of injections needed per week
• Potential increased risk of hypoglycemia reported
• Careful consideration of benefits versus risks recommended for patient management